Which has the lower trailing P/E, ANAB or ANIP?

ANAB has the lower trailing P/E: ANAB trades at 8.95 and ANIP at 15.40. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANAB or ANIP?

Over the past five years, ANIP grew revenue faster — ANAB at a 18.60% CAGR versus ANIP at 35.61%.

Is ANAB or ANIP more profitable?

ANAB runs the higher net margin — ANAB at 82.37% versus ANIP at 10.82%.

How have ANAB and ANIP total returns compared?

Over the past 5 years, ANAB delivered 21.54% and ANIP delivered 16.86% annualized total return. Past performance doesn't predict future results.

AnaptysBio, Inc. (ANAB) vs ANI Pharmaceuticals, Inc. (ANIP)

A side-by-side comparison of AnaptysBio, Inc. and ANI Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANAB

AnaptysBio, Inc.

$1.42B

$48.07HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

ANIP

ANI Pharmaceuticals, Inc.

$1.62B

$71.31HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — ANAB vs ANIP

growth of $100 · dividends reinvested · last 10y

ANAB +334.2% (+15.8%/yr)ANIP +25.8% (+2.3%/yr)ANAB compounded faster over this window

ANAB ANIP

ANAB vs ANIP: by the numbers

•ANIP is the larger company ($1.62B vs $1.42B market cap).
•ANAB trades at the lower trailing earnings multiple (8.95 vs 15.40 P/E), one valuation lens rather than an overall verdict.
•ANAB converts more revenue to profit (82.37% vs 10.82% net margin).
•ANIP grew revenue faster over the past five years (35.61% vs 18.60% CAGR).

Metrics side by side

Valuation

Metric	ANAB	ANIP
P/E ratio	8.95	15.40
Forward P/E	N/A	7.69
P/S ratio	5.99	1.66
P/B ratio	134.46	2.71
EV / EBITDA	11.48	6.74
FCF yield	1.27%	N/A

Profitability

Metric	ANAB	ANIP
Gross margin	98.97%	51.01%
Operating margin	20.42%	15.35%
Net margin	82.37%	10.82%
ROE	1849.06%	17.72%
ROIC	47.55%	9.26%

Growth (annualized)

Metric	ANAB	ANIP
Revenue CAGR (5Y)	18.60%	35.61%
FCF CAGR (5Y)	27.41%	N/A
Total return CAGR (5Y)	21.54%	16.86%

Frequently asked

Which has the lower trailing P/E, ANAB or ANIP?: ANAB has the lower trailing P/E: ANAB trades at 8.95 and ANIP at 15.40. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANAB or ANIP?: Over the past five years, ANIP grew revenue faster — ANAB at a 18.60% CAGR versus ANIP at 35.61%.
Is ANAB or ANIP more profitable?: ANAB runs the higher net margin — ANAB at 82.37% versus ANIP at 10.82%.
How have ANAB and ANIP total returns compared?: Over the past 5 years, ANAB delivered 21.54% and ANIP delivered 16.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysis Full ANIP analysis Interactive comparison tool

Dig into the metrics

AnaptysBio P/E ratio ANI Pharmaceuticals P/E ratio AnaptysBio ROE ANI Pharmaceuticals ROE AnaptysBio operating margin ANI Pharmaceuticals operating margin AnaptysBio revenue growth ANI Pharmaceuticals revenue growth AnaptysBio free cash flow ANI Pharmaceuticals free cash flow

AnaptysBio & ANI Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.